Stoke Therapeutics (STOK) Return on Capital Employed (2022 - 2025)
Historic Return on Capital Employed for Stoke Therapeutics (STOK) over the last 4 years, with Q3 2025 value amounting to 0.08%.
- Stoke Therapeutics' Return on Capital Employed rose 5500.0% to 0.08% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.08%, marking a year-over-year increase of 5500.0%. This contributed to the annual value of 0.48% for FY2024, which is 600.0% up from last year.
- According to the latest figures from Q3 2025, Stoke Therapeutics' Return on Capital Employed is 0.08%, which was up 5500.0% from 0.11% recorded in Q2 2025.
- Over the past 5 years, Stoke Therapeutics' Return on Capital Employed peaked at 0.13% during Q1 2025, and registered a low of 0.65% during Q1 2024.
- For the 4-year period, Stoke Therapeutics' Return on Capital Employed averaged around 0.35%, with its median value being 0.45% (2022).
- In the last 5 years, Stoke Therapeutics' Return on Capital Employed tumbled by -2100bps in 2024 and then surged by 7800bps in 2025.
- Stoke Therapeutics' Return on Capital Employed (Quarter) stood at 0.44% in 2022, then fell by -27bps to 0.56% in 2023, then rose by 26bps to 0.42% in 2024, then surged by 120bps to 0.08% in 2025.
- Its Return on Capital Employed stands at 0.08% for Q3 2025, versus 0.11% for Q2 2025 and 0.13% for Q1 2025.